FABP4 and neoplasm: In tumours treated with BEV and DBZ combined, vessels with strong FABP4 staining were significantly less than in dimethylsulphoxide-treated DLL4-overexpressing tumours, and no difference to EV tumours was observed (Figures 1a and b).